Skip to content

SIE-1

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523269-31-00
Enrollment
57
Registered
2026-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hormone receptor-positive early breast cancer in post-menopausal women

Interventions

None listed

Sponsors

Laboratorios Farmaceuticos Rovi S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 1, 2026